Breadcrumb

What's New at the RI-MUHC ?

Krembil funds help researchers seek answers to misfiring of brain’s immune system in battling Alzheimer’s

A grant of $2.4 million will enable Greg Fonseca of the RI-MUHC and a team...

Pediatric egg-induced anaphylaxis characteristics, outcomes described in new publication

A team led by Moshe Ben-Shoshan has recruited the largest known cohort of egg-related anaphylaxis patients...

New findings illustrate pathway for screening high-risk individuals for pancreatic cancer

An international collaboration of scientists and healthcare professionals is developing a promising surveillance...

$10.6M grant supports innovative autism project

McGill Translational Platform in Autism Research will help uncover the disorders’ neural foundations

Beyond accessibility

How the Jooay App helps families find inclusive play opportunities for children with disabilities and connects families to their communities

Psychologist Tina Montreuil is making a difference

RI-MUHC researcher invited to provide expert testimony to the House of Commons regarding her project, the Montreal Antenatal Well-Being Study...

A new hope for men with metastatic prostate cancer

MUHC patients are the first enrolled in a new global Phase 1 clinical trial testing Actinium-225, a therapeutic agent used in nuclear precision medicine

Genetic causes of cerebral palsy uncovered through whole-genome sequencing

Canadian scientists demonstrate that cerebral palsy may be caused by both genetic and environmental factors...

A roadmap to improving healthcare disparities in northern Quebec

Some Indigenous communities are too short-staffed to perform lifesaving procedures, McGill study finds

New Global TB Dictionary aims to standardize terminology in tuberculosis research

The Lancet Global Health highlights the launch of the dictionary created in part at the RI-MUHC.

Learn more about the RI-MUHC